The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture of chemicals and pharmaceuticals Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
950 - 1,350 jobs Number of planned job losses
800 jobs Number of planned job creations
Announcement Date
10 March 2025
Employment effect (start)
10 March 2025
Foreseen end date
31 December 2026
Description
German biotechnology company BioNTech has announced plans to cut between 950 and 1,350 positions worldwide by the end of 2026.
The restructuring programme will mainly affect its late-stage mRNA manufacturing site in Germany and research operations in Europe and in the United States. In Germany, around 250 to 350 jobs are expected to be lost in Marburg, and up to 150 in Idar-Oberstein.
The decision follows a steep financial downturn, with BioNTech reporting a net loss of approximately €700 million in 2024. The restructuring supports BioNTech’s strategic shift towards developing mRNA-based cancer therapies, with the first approvals anticipated by 2026.
Alongside the layoffs, the company plans to create 800 to 1,200 new jobs, notably expanding its Mainz headquarters (the business expansion was recorded in the ERM database: BioNTech 2022-DE.
Founded in 2008, BioNTech is headquartered in Mainz, Germany, and focuses on individualized immunotherapies for cancer and other serious diseases. The company operates in Germany, UK, Austria, France, Netherlands, United States, Singapore, China, Turkey, Australia. Rwanda, employing about 7,000 people worldwide.
Eurofound (2025), BioNTech, Internal restructuring in World, factsheet number 202675, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/202675.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
